サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1451733

豚ヘルスケア市場レポート：製品、疾患、投与経路、流通チャネル、地域別、2024-2032

Swine Healthcare Market Report by Product, Disease, Route of Administration, Distribution Channel, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 143 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
豚ヘルスケア市場レポート：製品、疾患、投与経路、流通チャネル、地域別、2024-2032
出版日: 2024年03月02日
発行: IMARC
ページ情報: 英文 143 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の豚ヘルスケア市場規模は2023年に30億米ドルに達しました。今後、IMARC Groupは、2024年から2032年の間に6.48%の成長率（CAGR）を示し、2032年までに53億米ドルに達すると予測しています。豚製品への依存度の増加、商業養豚と輸出活動の大幅な増加、豚伝染病に対する意識の高まりが、市場を牽引する主な要因のいくつかです。

豚ヘルスケアは、豚の疾病時の不快感を軽減することを目的とした製品、治療手順、診断キットの幅広いカテゴリーを指します。不妊症や先天異常のような一般的な豚関連疾患の治療や、そのような疾患を予防するための治療薬の開発に重点が置かれています。調整された世界の疾病モニタリング、将来の脅威の影響を最小限に抑えるための的を絞った調査投資、データ分析は、豚ヘルスケア管理の一部です。また、適切な時期にワクチン接種を行い、責任を持って抗生物質を使用することで、豚の疾病に対する免疫力を高めながら、ウイルスや細菌を予防することも重要です。豚へのヘルスケアサービスの提供に加え、豚舎設計、豚の移動、ワクチン接種プロトコル、牛群の健康モニタリング、疾病サーベイランス、状況に応じた診断検査を通じて、疾病リスクの最小化を推進します。

大衆の間で豚肉製品への依存度が高まっていることが、市場の成長を促進する主な要因のひとつです。これは、世界中で商業的養豚と輸出活動が大幅に増加していることに起因しています。これに伴い、豚インフルエンザ、サルモネラ菌、肺炎マイコプラズマ、古典的豚熱（CSF）など、多くの疾病の流行が増加していることが、市場の成長を後押ししています。さらに、豚が媒介する病気に対する意識の高まりが、豚ヘルスケア製品の普及につながっています。また、豚の健康維持に向けた政府機関の積極的な取り組みも、市場の成長を後押ししています。豚を食べる人口が増え続けていることが、健康な豚家畜の需要を後押ししており、これがさらに市場に拍車をかけています。これに加えて、豚インフルエンザや豚熱を予防し、豚の病気が人間に及ぼす影響を軽減するワクチンの開発に重点を置いた広範な研究開発（R&D）活動が、市場に貢献しています。さらに、動物病院における画像診断の導入が増加し、付属品や診断機器の需要が高まっていることも市場に貢献しています。市場の見通しを明るいものにしているその他の要因としては、家畜生産を増加させるためのワクチン、抗生物質、外科的治療の採用率の増加、食中毒の発生率の大幅な上昇、急速な世界化、有機豚肉への需要の加速、飲食品（F&B）業界の大幅な成長などがあります。

本レポートで扱う主な質問

  • 世界の豚ヘルスケア市場の規模は？
  • 2024年から2032年にかけての世界の豚肉ヘルスケア市場の予想成長率は？
  • 世界の豚ヘルスケア市場を牽引する主な要因は何か？
  • COVID-19が世界の豚ヘルスケア市場に与えた影響は？
  • 豚ヘルスケアの世界市場の製品別区分は？
  • 豚ヘルスケアの世界市場の疾患別区分は？
  • 豚ヘルスケアの世界市場における主要地域は？
  • 豚ヘルスケアの世界市場における主要プレーヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 豚ヘルスケア世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 診断検査
    • 市場動向
    • 主要セグメント
      • 酵素結合免疫吸着測定法（ELISA）
      • 迅速免疫移行法（RIM）
      • 寒天ゲル免疫拡散法（AGID）
      • ポリメラーゼ連鎖反応（PCR）
      • 画像診断
      • その他
    • 市場予測
  • 治療薬
    • 市場動向
    • 主要セグメント
      • ワクチン
      • 寄生虫駆除薬
      • 抗感染症剤
      • 飼料添加物
      • その他
    • 市場予測

第7章 市場内訳：疾患別

  • 滲出性皮膚炎
    • 市場動向
    • 市場予測
  • コクシジウム症
    • 市場動向
    • 市場予測
  • 呼吸器疾患
    • 市場動向
    • 市場予測
  • 豚赤痢
    • 市場動向
    • 市場予測
  • 豚パルボウイルス
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：投与経路別

  • 注射剤
    • 市場動向
    • 市場予測
  • 経口剤
    • 市場動向
    • 市場予測

第9章 市場内訳：流通チャネル別

  • 動物病院
    • 市場動向
    • 市場予測
  • 小売薬局
    • 市場動向
    • 市場予測
  • オンライン薬局
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 促進要因、抑制要因、機会

  • 市場概要
  • 促進要因
  • 抑制要因
  • 機会

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Boehringer Ingelheim International GmbH
    • Ceva Animal Health Inc.
    • Elanco
    • IDEXX Laboratories Inc.
    • Innovative Diagnostic
    • Merck & Co. Inc.
    • Phibro Animal Health Corporation
    • Vetoquinol
    • Virbac Corporation
    • Zoetis Inc.
図表

List of Figures

  • Figure 1: Global: Swine Healthcare Market: Major Drivers and Challenges
  • Figure 2: Global: Swine Healthcare Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Swine Healthcare Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Swine Healthcare Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Swine Healthcare Market: Breakup by Disease (in %), 2023
  • Figure 6: Global: Swine Healthcare Market: Breakup by Route of Administration (in %), 2023
  • Figure 7: Global: Swine Healthcare Market: Breakup by Distribution Channel (in %), 2023
  • Figure 8: Global: Swine Healthcare Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Swine Healthcare (Diagnostic Tests) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Swine Healthcare (Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Swine Healthcare (Therapeutics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Swine Healthcare (Therapeutics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Swine Healthcare (Exudative Dermatitis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Swine Healthcare (Exudative Dermatitis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Swine Healthcare (Coccidiosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Swine Healthcare (Coccidiosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Swine Healthcare (Respiratory Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Swine Healthcare (Respiratory Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Swine Healthcare (Swine Dysentery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Swine Healthcare (Swine Dysentery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Swine Healthcare (Porcine Parvovirus) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Swine Healthcare (Porcine Parvovirus) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Swine Healthcare (Other Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Swine Healthcare (Other Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Swine Healthcare (Injectable) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Swine Healthcare (Injectable) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Swine Healthcare (Oral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Swine Healthcare (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Swine Healthcare (Veterinary Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Swine Healthcare (Veterinary Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Swine Healthcare (Retail Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Swine Healthcare (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Swine Healthcare (Online Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Swine Healthcare (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: North America: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: North America: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: United States: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: United States: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Canada: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Canada: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Asia-Pacific: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Asia-Pacific: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: China: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: China: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Japan: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Japan: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: India: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: India: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: South Korea: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: South Korea: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Australia: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Australia: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Indonesia: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Indonesia: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Others: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Others: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Europe: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Europe: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Germany: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Germany: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: France: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: France: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: United Kingdom: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: United Kingdom: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Italy: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Italy: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Spain: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Spain: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Russia: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Russia: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Others: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Others: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Latin America: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Latin America: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Brazil: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Brazil: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Mexico: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Mexico: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Others: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Others: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Middle East and Africa: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Middle East and Africa: Swine Healthcare Market: Breakup by Country (in %), 2023
  • Figure 83: Middle East and Africa: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Global: Swine Healthcare Industry: Drivers, Restraints, and Opportunities
  • Figure 85: Global: Swine Healthcare Industry: Value Chain Analysis
  • Figure 86: Global: Swine Healthcare Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Swine Healthcare Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Swine Healthcare Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Swine Healthcare Market Forecast: Breakup by Disease (in Million US$), 2024-2032
  • Table 4: Global: Swine Healthcare Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 5: Global: Swine Healthcare Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 6: Global: Swine Healthcare Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Swine Healthcare Market: Competitive Structure
  • Table 8: Global: Swine Healthcare Market: Key Players
目次
Product Code: SR112024A6654

The global swine healthcare market size reached US$ 3.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.48% during 2024-2032. The increasing dependency on swine products, a considerable rise in commercial swine farming and export activities, and the growing awareness regarding pork-transmitted diseases represent some of the key factors driving the market.

Swine healthcare refers to a broad category of products, treatment procedures, and diagnostic kits that aim to alleviate discomfort during swine diseases. It focuses on treatments for common pig-related disorders like infertility and congenital anomalies as well as the development of therapeutics to prevent such diseases. Coordinated global disease monitoring, targeted research investments that minimize future threat effects, and data analysis are part of swine healthcare management. Along with this, it involves the prevention of viruses and bacteria while enhancing herd disease immunity with appropriately timed vaccinations and responsible antibiotic use. In addition to providing health services to pigs, the swine healthcare system promotes minimizing disease risks through barn design, pig movement, vaccination protocols, herd health monitoring, disease surveillance, and diagnostic tests that are appropriate for the situation.

The increasing dependency on swine products among the masses is one of the key factors driving the growth of the market. This can be attributed to a considerable rise in commercial swine farming and export activities across the globe. In line with this, the rising prevalence of numerous diseases, including swine flu, salmonella, mycoplasma hyopneumoniae, and classical swine fever (CSF), is fueling the market. Moreover, the augmenting awareness regarding pork-transmitted diseases is resulting in a higher uptake of swine healthcare products. Also, favorable initiatives taken by government bodies toward swine health maintenance are fueling the market growth. The continuously growing pork-eating population is propelling the demand for healthy swine livestock, which is further providing an impetus to the market. Besides this, extensive research and development (R&D) activities with an enhanced focus on the development of vaccines to prevent swine flu and swine fever and reduce the effects of swine diseases on humans are contributing to the market. Additionally, the augmenting incorporation of diagnostic imaging in veterinary hospitals leading to an escalating demand for accessories and diagnostic equipment is contributing to the market. Some of the other factors creating a positive market outlook include the growing adoption rates of vaccines, antibiotics, and surgical treatments for increasing livestock production, a significant rise in the rates of foodborne diseases, rapid globalization, the accelerating demand for organic pork, and considerable growth in the food and beverage (F&B) industry.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global swine healthcare market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on product, disease, route of administration and distribution channel.

Product Insights:

Diagnostic Tests

Enzyme Linked Immuno-Sorbent Assay (ELISA)

Rapid Immuno Migration (RIM)

Agar Gel Immuno-Diffusion (AGID)

Polymerase Chain Reaction (PCR)

Diagnostic Imaging

Others

Therapeutics

Vaccines

Parasiticides

Anti-infectives

Feed Additives

Others

The report has also provided a detailed breakup and analysis of the swine healthcare market based on the product. This includes diagnostic tests (Enzyme Linked Immuno-Sorbent Assay (ELISA), Rapid Immuno Migration (RIM), Agar Gel Immuno-Diffusion (AGID), Polymerase Chain Reaction (PCR), Diagnostic Imaging, and others) and therapeutics (vaccines, parasiticides, anti-infectives, feed additives, and others). According to the report, therapeutics represented the largest segment.

Disease Insights:

Exudative Dermatitis

Coccidiosis

Respiratory Diseases

Swine Dysentery

Porcine Parvovirus

Others

A detailed breakup and analysis of the swine healthcare market based on the disease has also been provided in the report. This includes exudative dermatitis, coccidiosis, respiratory diseases, swine dysentery, porcine parvovirus, and others. According to the report, respiratory diseases accounted for the largest market share.

Route of Administration Insights:

Injectable

Oral

A detailed breakup and analysis of the swine healthcare market based on the route of administration has also been provided in the report. This includes injectable and oral.

Distribution Channel Insights:

Veterinary Hospitals

Retail Pharmacy

Online Pharmacy

A detailed breakup and analysis of the swine healthcare market based on the distribution channel has also been provided in the report. This includes veterinary hospitals, retail pharmacy and online pharmacy.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for swine healthcare. Some of the factors driving the North America swine healthcare market included the growing consumption of pork, improving animal healthcare infrastructure, the growing consciousness regarding pork-transmitted diseases, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global swine healthcare market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Boehringer Ingelheim International GmbH, Ceva Animal Health Inc., Elanco, IDEXX Laboratories Inc., Innovative Diagnostic, Merck & Co. Inc., Phibro Animal Health Corporation, Vetoquinol, Virbac Corporation, Zoetis Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1. How big is the global swine healthcare market?
  • 2. What is the expected growth rate of the global swine healthcare market during 2024-2032?
  • 3. What are the key factors driving the global swine healthcare market?
  • 4. What has been the impact of COVID-19 on the global swine healthcare market?
  • 5. What is the breakup of the global swine healthcare market based on the product?
  • 6. What is the breakup of the global swine healthcare market based on the disease?
  • 7. What are the key regions in the global swine healthcare market?
  • 8. Who are the key players/companies in the global swine healthcare market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Swine Healthcare Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Diagnostic Tests
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Enzyme Linked Immuno-Sorbent Assay (ELISA)
      • 6.1.2.2 Rapid Immuno Migration (RIM)
      • 6.1.2.3 Agar Gel Immuno-Diffusion (AGID)
      • 6.1.2.4 Polymerase Chain Reaction (PCR)
      • 6.1.2.5 Diagnostic Imaging
      • 6.1.2.6 Others
    • 6.1.3 Market Forecast
  • 6.2 Therapeutics
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Vaccines
      • 6.2.2.2 Parasiticides
      • 6.2.2.3 Anti-infectives
      • 6.2.2.4 Feed Additives
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Disease

  • 7.1 Exudative Dermatitis
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Coccidiosis
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Respiratory Diseases
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Swine Dysentery
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Porcine Parvovirus
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Injectable
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Oral
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Veterinary Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Retail Pharmacy
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Online Pharmacy
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

  • 11.1 Overview
  • 11.2 Drivers
  • 11.3 Restraints
  • 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Boehringer Ingelheim International GmbH
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Ceva Animal Health Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Elanco
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
    • 15.3.4 IDEXX Laboratories Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Innovative Diagnostic
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Merck & Co. Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Phibro Animal Health Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Vetoquinol
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 Virbac Corporation
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Zoetis Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report